This website uses cookies.

By clicking the "Accept" button or continuing to browse our site, you agree to first-party and session-only cookies being stored on your device to enhance site navigation and analyze site performance and traffic. For more information on our use of cookies, please see our Privacy Policy.

  1. Home
  2. Journals
  3. American Economic Review
  4. May 2006
  5. Did Medicare Induce Pharmaceutical Innovation?

American Economic Review

ISSN 0002-8282 (Print) | ISSN 1944-7981 (Online)

Did Medicare Induce Pharmaceutical Innovation?

  • Daron Acemoglu
  • David Cutler
  • Amy Finkelstein
  • Joshua Linn
American Economic Review
vol. 96, no. 2, May 2006
(pp. 103–107)
Download Full Text PDF

Citation

Acemoglu, Daron, David Cutler, Amy Finkelstein, and Joshua Linn. 2006. "Did Medicare Induce Pharmaceutical Innovation?" American Economic Review 96 (2): 103–107. DOI: 10.1257/000282806777211766

JEL Classification

  • I18 Health: Government Policy; Regulation; Public Health
  • L65 Chemicals; Rubber; Drugs; Biotechnology
  • O31 Innovation and Invention: Processes and Incentives